Seqirus – FLUCELVAX QUADRIVALENT Approved for Children As Young as Six Months Old
Returning guest, Dave Ross, Vice President, Commercial Operations, North America at Seqirus discusses the FDA approval of the first and only cell-based ...
5305 articles
Returning guest, Dave Ross, Vice President, Commercial Operations, North America at Seqirus discusses the FDA approval of the first and only cell-based ...
David McNally, CEO of Titan Medical, a medical device company that is focused on enhancing robotic single access surgery, discusses the development of a...
Gregg Sylvester, MD, Chief Medical Officer at Seqirus, one of the world’s largest influenza vaccine providers discusses some new real-world evidenc...
Ronald Martell, President and CEO at MorphImmune discusses MorphImmune's proprietary platform that enables reprogramming or removal of aberrant cells wi...
Angela Stoehr, OB/GYN, addresses how the pandemic exacerbated the opioid epidemic and the need to refocus on non-opioid pain management approaches after...
Sham Dholakia, MD, Chief Medical Officer at CareDx, a company focused on high-value healthcare solutions for transplant patients, discusses the Assessin...
Amir Mansouri, PhD, CEO and Co-Founder of SprintRay, discusses how his vision to revolutionize the dental industry with new “on-demand” 3D printing ...
Samuel Kim, a thoracic surgeon at Northwestern Medicine discusses the Ambulatory Precision Lung Sparing (A-PLUS) surgery program born from the need to b...
Campbell Rogers, Executive Vice President and Chief Medical Officer at HeartFlow discusses some of the latest developments in cardiovascular care, inclu...
Brian Koffman, Executive Vice President and Chief Medical Officer, CLL (chronic lymphocytic leukemia) Society and a CLL patient discusses the impact and...